Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-10-04 00:00:00 ET · period of report 2023-10-02 · accession 0001209191-23-052066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-04 | 2023-10-02 | RXRX | Dar Zavain | Dir | A - Grant | $0.00 | +1,920 | 74.0K | +3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-10-02 | A | A | 1,920 | $0.00 | 73,964 | D | — | — | (F1) The shares were issued pursuant to the Issuer's Outside Director Compensation Policy |